You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Drugs

The drug library provides access to information on over 100 cancer drugs available for use in Canada.

Find more safety information in the supplementary patient handout How to Safely Take Your Oral Anti-Cancer Medication.

Displaying Drugs List

10 Items
Other Name(s): Provera® (multiple brands available)
Funding:
ODB - General Benefit
  • medroxyprogesterone
Apr 2015
Other Name(s): Megace® (multiple brands available)
Funding:
ODB - General Benefit
  • megestrol - oral tablets
Aug 2016
Other Name(s): Alkeran®
Funding:
ODB - General Benefit
  • melphalan - oral tablets
Jun 2019
Other Name(s): Purinethol®
Funding:
ODB - General Benefit
  • mercaptopurine
Jun 2019
Other Name(s): Uromitexan® (multiple brands available)
Nov 2017
Funding:
ODB - General Benefit
  • methotrexate - oral tablets
Jun 2019
Other Name(s): Rydapt™
Funding:
Exceptional Access Program
  • midostaurin - First-line treatment of adult patients diagnosed with FLT3-mutated acute myeloid leukemia, in combination with specific standard induction followed by consolidation chemotherapy, according to clinical criteria
Jun 2019
Other Name(s): Mutamycin® (generic brand available)
May 2018
Other Name(s): Lysodren®
Jun 2019
Other Name(s): Novantrone® (multiple brands available)
May 2018